X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (13101) 13101
Publication (1160) 1160
Book Review (80) 80
Book Chapter (32) 32
Conference Proceeding (23) 23
Dissertation (8) 8
Book / eBook (2) 2
Magazine Article (2) 2
Data Set (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (11125) 11125
male (7490) 7490
rats (7472) 7472
neurosciences (6977) 6977
substantia-nigra (4707) 4707
substantia nigra - drug effects (4652) 4652
parkinson's disease (3812) 3812
index medicus (3719) 3719
dopamine - metabolism (3472) 3472
dopamine (3424) 3424
substantia nigra (3342) 3342
substantia nigra - metabolism (2845) 2845
humans (2841) 2841
parkinsons-disease (2721) 2721
rats, sprague-dawley (2645) 2645
neurons - drug effects (2613) 2613
mice (2452) 2452
neurons (2425) 2425
corpus striatum - drug effects (2307) 2307
female (2208) 2208
brain (1892) 1892
substantia nigra - physiology (1795) 1795
disease models, animal (1765) 1765
corpus striatum - metabolism (1741) 1741
pharmacology & pharmacy (1733) 1733
tyrosine 3-monooxygenase - metabolism (1539) 1539
neurons - metabolism (1527) 1527
rats, wistar (1517) 1517
basal ganglia (1510) 1510
substantia nigra - pathology (1392) 1392
dose-response relationship, drug (1357) 1357
dopamine - physiology (1356) 1356
motor activity - drug effects (1348) 1348
oxidative stress (1327) 1327
mice, inbred c57bl (1261) 1261
striatum (1212) 1212
rats, inbred strains (1185) 1185
biochemistry & molecular biology (1175) 1175
neurons - physiology (1137) 1137
neurology (1127) 1127
nervous system (1099) 1099
rat (1093) 1093
behavior, animal - drug effects (1078) 1078
time factors (1065) 1065
immunohistochemistry (1006) 1006
clinical neurology (987) 987
neurodegeneration (969) 969
mptp (958) 958
substantia nigra - cytology (955) 955
ventral tegmental area (944) 944
neurodegenerative diseases (939) 939
6-hydroxydopamine (878) 878
oxidopamine (856) 856
parkinson disease - metabolism (842) 842
apomorphine - pharmacology (818) 818
brain - drug effects (818) 818
dopaminergic-neurons (812) 812
parkinson disease - drug therapy (810) 810
movement disorders (803) 803
neuroprotective agents - pharmacology (788) 788
analysis (785) 785
substantia nigra - physiopathology (777) 777
in-vivo (770) 770
parkinsons disease (769) 769
neuroprotection (754) 754
brain - metabolism (738) 738
article (709) 709
neurotoxicity (709) 709
rodents (699) 699
corpus striatum - physiology (693) 693
rat-brain (677) 677
cells, cultured (669) 669
alpha-synuclein (668) 668
parkinson disease - pathology (668) 668
parkinson’s disease (655) 655
neurons - pathology (646) 646
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (623) 623
parkinson disease - physiopathology (622) 622
dopamine receptors (620) 620
in vitro techniques (618) 618
dopaminergic neurons - drug effects (606) 606
apoptosis (602) 602
psychiatry (594) 594
nucleus-accumbens (579) 579
oxidopamine - toxicity (568) 568
multidisciplinary sciences (564) 564
receptors, dopamine - drug effects (564) 564
gaba (544) 544
corpus striatum - pathology (542) 542
stereotyped behavior - drug effects (537) 537
neostriatum (529) 529
physiological aspects (527) 527
haloperidol - pharmacology (526) 526
3,4-dihydroxyphenylacetic acid - metabolism (521) 521
research (518) 518
phenols (512) 512
analysis of variance (509) 509
central-nervous-system (502) 502
neuroscience (502) 502
parkinson disease, secondary - chemically induced (502) 502
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (12900) 12900
Russian (79) 79
French (35) 35
Chinese (31) 31
German (29) 29
Japanese (17) 17
Spanish (12) 12
Polish (9) 9
Ukrainian (5) 5
Dutch (3) 3
Italian (3) 3
Croatian (1) 1
Norwegian (1) 1
Persian (1) 1
Portuguese (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Neurobiology of Disease, ISSN 0969-9961, 2015, Volume 82, pp. 185 - 199
Journal Article
Journal Article
Journal of Neurochemistry, ISSN 0022-3042, 03/2010, Volume 112, Issue 6, pp. 1465 - 1476
Journal Article
Toxicology Letters, ISSN 0378-4274, 01/2016, Volume 243, pp. 7 - 21
Journal Article
Neurobiology of Disease, ISSN 0969-9961, 2009, Volume 34, Issue 2, pp. 279 - 290
Abstract The systemic rotenone model of Parkinson's disease (PD) accurately replicates many aspects of the pathology of human PD and has provided insights into... 
Neurology | Postural instability | Parkinson's disease | Dopamine | Behavior | Neurodegeneration | Rotenone | RISK-FACTORS | PROTECTION | RATS | ALPHA-SYNUCLEIN | SUBSTANTIA-NIGRA | NEUROTOXICITY | NEUROSCIENCES | DEGENERATION | 6-OHDA LESIONS | EXPOSURE | Substantia Nigra - physiopathology | Neurons - pathology | Tyrosine 3-Monooxygenase - metabolism | Dyskinesia, Drug-Induced - physiopathology | Substantia Nigra - pathology | Nerve Degeneration - physiopathology | Rats, Inbred Lew | Male | Hypokinesia - chemically induced | Nerve Degeneration - chemically induced | alpha-Synuclein - drug effects | Dopamine - deficiency | Muscle Rigidity - chemically induced | Rotenone - toxicity | Neurons - metabolism | Neurons - drug effects | Ubiquitins - metabolism | Disease Models, Animal | Parkinsonian Disorders - physiopathology | Reproducibility of Results | Injections, Intraperitoneal | Rats | Neurotoxins - toxicity | Parkinsonian Disorders - chemically induced | Tyrosine 3-Monooxygenase - drug effects | Dyskinesia, Drug-Induced - pathology | Nerve Degeneration - pathology | Uncoupling Agents - toxicity | Substantia Nigra - drug effects | Animals | Parkinsonian Disorders - pathology | Ubiquitins - drug effects | alpha-Synuclein - metabolism | Tyrosine | Analysis | rotenone | neurodegeneration | postural instability | behavior | dopamine
Journal Article
Journal Article
Neuropsychopharmacology, ISSN 0893-133X, 2014, Volume 39, Issue 5, pp. 1066 - 1080
Methamphetamine is a widely abused illicit drug. Recent epidemiological studies showed that methamphetamine increases the risk for developing Parkinson's... 
silver-degeneration stain | neurotoxicity | Parkinson's disease | psychostimulants | cell death | amphetamine derivatives | MOUSE STRIATUM | PSYCHIATRY | D-1 | SUBSTANTIA-NIGRA | NEUROSCIENCES | STRIATAL DOPAMINE | NEURONS | PHARMACOLOGY & PHARMACY | MICE | RECEPTORS | BRAIN | PARKINSONS-DISEASE | Immunohistochemistry | Motor Activity - physiology | Neurons - pathology | Tyrosine 3-Monooxygenase - metabolism | Neural Pathways - drug effects | Substantia Nigra - pathology | Apoptosis - drug effects | Dopaminergic Neurons - pathology | Motor Activity - drug effects | Male | Neural Pathways - pathology | Substantia Nigra - metabolism | Corpus Striatum - metabolism | Necrosis - pathology | Nerve Degeneration - chemically induced | Nerve Degeneration - metabolism | Dose-Response Relationship, Drug | Dopamine Agents - pharmacology | Dopaminergic Neurons - metabolism | Dopaminergic Neurons - drug effects | Neurons - metabolism | Neurons - drug effects | Corpus Striatum - pathology | Methamphetamine - pharmacology | Mice, Inbred C57BL | Silver Staining | Axons - drug effects | Axons - metabolism | Mice, Transgenic | Necrosis - metabolism | Nerve Degeneration - pathology | Necrosis - chemically induced | Substantia Nigra - drug effects | Animals | Axons - pathology | Corpus Striatum - drug effects | Neural Pathways - metabolism | Mice | Apoptosis - physiology | Index Medicus | Neuroprotection | Addiction & Substance Abuse | Dopamine | Neurodegeneration | Parkinson's Disease | Movement Disorders | Original
Journal Article
Journal Article
Annals of Neurology, ISSN 0364-5134, 03/2014, Volume 75, Issue 3, pp. 351 - 362
Journal Article